| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/22/2004 | EP1458694A2 Therapeutic compounds for treating dyslipidemic conditions |
| 09/22/2004 | EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458679A2 Pyrrolidine derivatives as prostaglandin modulators |
| 09/22/2004 | EP1458677A1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458673A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 09/22/2004 | EP1458672A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
| 09/22/2004 | EP1458412A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 09/22/2004 | EP1458397A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
| 09/22/2004 | EP1458395A1 New use |
| 09/22/2004 | EP1458394A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458389A1 Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458382A1 Amide derivatives as gk activators |
| 09/22/2004 | EP1458381A1 Triazoles as oxytocin antagonists |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458370A1 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine |
| 09/22/2004 | EP1268389B1 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| 09/22/2004 | EP1265904B1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 09/22/2004 | EP1153014B1 Beta-alanine derivatives |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1141251A4 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 09/22/2004 | EP1140981B1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1098646B1 Stabilized carvedilol injection solution |
| 09/22/2004 | EP1077950B1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP1012164B1 Serine protease inhibitors |
| 09/22/2004 | EP0938500B1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/22/2004 | EP0914119B1 Process for forming solid oral dosage forms of valsartan |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531592A Process for preparation of neutrophil inhibitory factor |
| 09/22/2004 | CN1531590A Aspergillus ocharceus 11 alpha hydroxylase and oxidoreductase |
| 09/22/2004 | CN1531555A Glycosaminoglycans derived from K5 polysaccharide having high antithrombin activity and process for their preparation |
| 09/22/2004 | CN1531554A Humanized antibodies derived from DD-3B6-22, specific for D-dimer fragment of fibrin |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531536A Process for preparation of pyrazolo[4,3-D] pyrimidine derivative |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531427A Premixed amiodarone parenteral solution and method for making the same |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1531422A Gene delivery formulations and methods for treatment of ischemic conditions |
| 09/22/2004 | CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
| 09/22/2004 | CN1530363A Method of extracting terpene lactone from folium ginkgo leaves and product |
| 09/22/2004 | CN1530117A Buyiqiangxin tablets for heart and preparation thereof |
| 09/22/2004 | CN1530114A Sustained releasing breviscapine tablets |
| 09/22/2004 | CN1530113A Breviscapine disperisng tablets composition and its preparation |
| 09/22/2004 | CN1530110A Naloxone freeze-drying powder injection and preparing technology thereof |
| 09/22/2004 | CN1530109A Use of oxidized matrine in preparation of chemicals for treating viral myocarditis |
| 09/22/2004 | CN1530107A Insulin resistance treatment by growth hormone secretory hormone |
| 09/22/2004 | CN1530102A Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
| 09/22/2004 | CN1530100A Food containing Angelica sinensis extractive and medicine composition thereof |
| 09/22/2004 | CN1167801C Constitution of recombinant human VEGF adenovirus carrier |
| 09/22/2004 | CN1167709C N-pyrazole AZA receptor agonists |
| 09/22/2004 | CN1167697C Benzopyran derivative |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
| 09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
| 09/22/2004 | CN1167670C Aryl carboxylic acid and tetrazole derivant |
| 09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/22/2004 | CN1167467C Antiswelling medicine |
| 09/22/2004 | CN1167458C Capsules and tablets for cardiovascular diseases and cerebrovascular diseases |
| 09/22/2004 | CN1167453C Powder for curing hemorrhoid |
| 09/22/2004 | CN1167429C Medicine for treating cardiovascular disease to prevent coronary thrombosis and myocardial ischemia |
| 09/22/2004 | CN1167423C Means for treating radiation injuries |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/22/2004 | CN1167418C Use of nebivolol as anti-atherogenic |
| 09/22/2004 | CN1167416C Use of glucose uptake enhancer for reducing post-ischemic injury of heart |
| 09/22/2004 | CN1167413C Aerosol ointment compositions and preparation thereof |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 09/21/2004 | US6794405 Alicyclic imidazoles as H3 agents |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794399 Beta-adrenoreceptor and calcium channel blocking agent; induced vasorelaxing effect |
| 09/21/2004 | US6794388 Succinic acid salts of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794383 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters |
| 09/21/2004 | US6794375 Palatable arginine compounds and uses thereof for cardiovascular health |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |